European myocardial infarction (MI) market is estimated to grow modestly, at a CAGR of around 6.2%, during the forecast period. Rising heart patients, cohesive European healthcare policies, rising adoption of minimally invasive/non-invasive surgeries, and technological advancement in MI treatment is boosting the European MI treatment market. The European drug market is predicted to contribute highest in the growth of the MI treatment market followed by the device market due to the huge adoption of cardiology drugs, high cost of drugs, and favorable government policies. Europe region which includes UK, Spain, Germany, France, Italy, Sweden, and other EU countries have a significant number of CVD patients with heart diseases which are giving rise to the adoption of robotic surgeries and hybrid operating rooms.
Get Free Sample link @ https://www.omrglobal.com/request-sample/european-myocardial-infarction-market
Eastern Europe has the highest rates for CVD, CHD, and other heart diseases which create huge demand for cardiology related surgeries in the region. Europe has a quality healthcare system; however, the surgeries and medical devices are costly. In Europe, in April 2019, Britain’s heart Foundation has launched a global competition namely “The Big Bit Challenge” with the prize amounting to $39 million to propose a transformational solution to any CVD disease. Europe has a huge economic burden of lifestyle-oriented diseases such as CVD, CHD, MI treatment, stroke, and other heart diseases.
A full report of European Myocardial Infarction Market available @ https://www.omrglobal.com/industry-reports/european-myocardial-infarction-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
European Myocardial Infarction Market by Type
- Non-ST-elevation myocardial infarction (NSTEMI)
- ST-elevation myocardial infarction (STEMI)
- Silent Heart Attacks
European Myocardial Infarction Market by Device
- Left Ventricular Assist Device (LVAD)
- Pacemaker
- Catheters
- Implantable Cardioverter-Defibrillator (ICD)
- Others (Stent Graft)
European Myocardial Infarction Market by Diagnosis
- Electrocardiography (ECG)
- Chest X-Ray
- Computed Tomography (CT Scan)
- Echocardiography
- Others (Blood Test)
European Myocardial Infarction Market by Treatment
- Medication
- Analgesics
- Thrombolytic
- Antiplatelet Agents
- Glycoprotein IIb/IIIa Inhibitors
- Others (Beta-Adrenergic Blockers)
- Surgery
- Angioplasty
- Bypass Surgery
- Heart Transplant
European Myocardial Infarction Market by End-User
- Hospital & Clinics
- Ambulatory Surgical Centers
- Research Institutes
Regional Analysis
- UK
- Germany
- Italy
- France
- Spain
- Rest of Europe
Company Profiles
- Abbott Laboratories Inc.
- advanceCOR GmbH
- AstraZeneca PLC
- Bayer AG
- Boehringer Ingelheim International GmbH
- Boston Scientific Corp.
- Bristol-Myers Squibb Co.
- Eli Lilly and Co.
- GlaxoSmithKline Plc
- Johnson & Johnson Services, Inc.
- Koninklijke Philips N.V.
- Medtronic PLC
- Merck KGaA
- Mylan N.V.
- NeuroVive Pharmaceutical AB
- Novartis AG
- Pfizer Inc.
- PledPharma AB
- Sanofi SA
- Siemens AG
The Report Covers
- Comprehensive research methodology of the European myocardial infarction market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the European myocardial infarction market.
- Insights about market determinants which are stimulating the European myocardial infarction market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-myocardial-infarction-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
